Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

784 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

Willebrand International Non-interventional Global Surveillance

NCT01949220

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • Hopital des enfants Reine Fabiola Antwerp, Belgium
  • UZA hopital universitaire Edegem, Belgium
  • University Hospital Brno, Czechia
  • University Central Hospital Helsinki, Finland
View all 18 locations
View Trial Details
Completed

Study Evaluating Pharmacovigilance Of Refacto AF

NCT00895037

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • LKH - Univ. Klinikum Graz,Abt. fur Hamatologie Graz, Austria
  • Allgemeines Krankenhaus Linz, Kinderklinik Linz, Austria
  • Universitaetsklinik fuer Innere Medizin 1 Vienna, Austria
  • Sonnengesundheitszentrum München, Bavaria, Germany
View all 24 locations
View Trial Details
Completed

Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World

NCT01217255

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Universidade Estadual de Campinas, UNICAMP Campinas, São Paulo, Brazil
  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo São Paulo, Brazil
  • Universidade Federal de São Paulo (UNIFESP) São Paulo, Brazil
  • The Hospital for Sick Children Toronto, Ontario, Canada
View Trial Details
Completed

Study of Voncento® in Subjects With Von Willebrand Disease

NCT02552576

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • Study Site Vienna, Austria
  • Study Site Duisburg, Germany
  • Study Site Frankfurt, Germany
  • Study Site Athens, Greece
View Trial Details
Completed

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

NCT01395810

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site San Francisco, California, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
  • Novo Nordisk Investigational Site Jacksonville, Florida, United States
View all 49 locations
View Trial Details
Completed

Virtual Reality for Hemophilia

NCT03507582

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Nationwide Children's Hospital Columbus, Ohio, United States
View Trial Details

Related conditions